PubMed:23811343 / 346-469 JSONTXT

{"project":"Glycan-GlyCosmos","denotations":[{"id":"T5","span":{"begin":59,"end":70},"obj":"Glycan"}],"attributes":[{"id":"A5","pred":"glycosmos_id","subj":"T5","obj":"https://glycosmos.org/glycans/show/G43702JT"},{"id":"A32","pred":"image","subj":"T5","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT"}],"text":"These mutations are associated with a profound decrease in chondroitin N-acetylgalactosaminyltransferase-1 enzyme activity."}

{"project":"GlyCosmos-GlycoEpitope","denotations":[{"id":"T5","span":{"begin":59,"end":70},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A5","pred":"glycoepitope_id","subj":"T5","obj":"http://www.glycoepitope.jp/epitopes/EP0081"}],"text":"These mutations are associated with a profound decrease in chondroitin N-acetylgalactosaminyltransferase-1 enzyme activity."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T4","span":{"begin":0,"end":123},"obj":"Sentence"}],"text":"These mutations are associated with a profound decrease in chondroitin N-acetylgalactosaminyltransferase-1 enzyme activity."}

{"project":"GlyCosmos15-Glycan","denotations":[{"id":"T5","span":{"begin":59,"end":70},"obj":"Glycan"}],"attributes":[{"id":"A5","pred":"glycosmos_id","subj":"T5","obj":"https://glycosmos.org/glycans/show/G43702JT"},{"id":"A32","pred":"image","subj":"T5","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT"}],"text":"These mutations are associated with a profound decrease in chondroitin N-acetylgalactosaminyltransferase-1 enzyme activity."}

{"project":"GlyCosmos15-GlycoEpitope","denotations":[{"id":"T5","span":{"begin":59,"end":70},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A5","pred":"glycoepitope_id","subj":"T5","obj":"http://www.glycoepitope.jp/epitopes/EP0081"}],"text":"These mutations are associated with a profound decrease in chondroitin N-acetylgalactosaminyltransferase-1 enzyme activity."}